Abiopharma

🔍 Azagury Jacob (Executive)

Company: INSIGHT ENTERPRISES INC (NSIT)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 133,085 shares of Restricted Stock (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 133,085.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 42,588 shares of Restricted Stock (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 42,588.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 31,941 shares of Restricted Stock (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 31,941.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Acquired 31,941 shares of Restricted Stock (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: false | shares_owned_after: 31,941.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock of Insight Enterprises, Inc.
• F2: The number of restricted stock units earned is subject to the achievement of the absolute share price goals over a three year measurement period as defined in the grant agreement. Once earned, the restricted stock units will vest on April 15, 2029.
• F3: The restricted stock units were granted on April 15, 2026 with vesting to occur in three equal annual installments beginning April 15, 2027.
• F4: The number of restricted stock units increases or decreases with the Company's performance against specific objectives defined in advance of the grant date, and the restricted stock units will vest in three equal annual installments beginning February 20, 2027.
• F5: The number of restricted stock units increases or decreases with the Company performance over a three year measurement period against a specific objective defined in advance of the grant date, and, subject to achievement of the specific objective, the restricted stock units will vest upon compensation committee certification of the results.